Anti-inflammatory activity of novel natural plant extracts composition—Levidor TM
Open Access
- 1 January 2023
- journal article
- research article
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 77 (1) , 49-58
Abstract
Introduction: Due to the severe side effects of non-steroidal anti-inflammatory drugs, there is an urgent need to find new natural or synthetic chemicals that could act as selective inhibitors of cyclooxygenase-2 (COX-2). The most valuable source of new bioactive compounds and potential drugs are plants. The present study aimed at the investigation of Levidor TM , a patented composition based on oil from the seeds of Nigella sativa and extract from the root of Angelica archangelica, regarding its potential anti-inflammatory effects on the molecular level. Materials and Methods: Studies were carried out with the use of murine macrophages (RAW 264.7), human monocytes (U937), and rat pheochromocytoma (PC-12) cell lines. The cytotoxicity of the Levidor TM extract was evaluated by MTT assay. The concentration of pro-inflammatory cytokines (IL-6, TNF- α ) was evaluated by ELISA. Moreover, the analysis of COX-1 and COX-2 mRNA expression levels by RT-PCR, as well as protein level by Western blot and immunofluorescent staining, were assessed. Results: The Levidor TM extract did not impact cell growth and showed anti-inflammatory effect in the present study. It was able to decrease the level of IL-6, TNF- α and suppress transcription of COX-2, whereas it had no effect on COX-1. Conclusions: Obtained results showed that Levidor TM exhibits strong anti-inflammatory properties and may provide a significant alternative to traditionally used medicines in acute pain and chronic inflammation.Keywords
This publication has 30 references indexed in Scilit:
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- Coumarins from Angelica archangelica Linn. and their effects on anxiety-like behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2013
- Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitorsPharmacological Research, 2012
- Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathwayBritish Journal of Pharmacology, 2010
- Expression of COX-1 and COX-2 in the endometrium of cyclic, pregnant and in a model of pseudopregnant rats and their regulation by sex steroidsReproductive Biology and Endocrinology, 2010
- Cyclooxygenase products and atherosclerosisDrug Discovery Today: Therapeutic Strategies, 2008
- Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammationImmunology Letters, 2006
- Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinoneActa Diabetologica, 2005
- Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyondBritish Journal of Clinical Pharmacology, 2004
- Pharmacological and toxicological properties of Nigella sativaPhytotherapy Research, 2003